Detrusor overactivity successfully treated with duloxetine

Journal of Obstetrics and Gynaecology

Volumn 27, Issue 4, 2007, Pages 439-440

  Basu, M ^a   Duckett, J R A ^a  

^a MEDWAY MARITIME HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; ADRENERGIC RECEPTOR AFFECTING AGENT; THIOPHENE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CONSTIPATION; DETRUSOR DYSSYNERGIA; FEMALE; HUMAN; PRIORITY JOURNAL; MIDDLE AGED; OVERACTIVE BLADDER;

ADRENERGIC UPTAKE INHIBITORS; FEMALE; HUMANS; MIDDLE AGED; THIOPHENES; URINARY BLADDER, OVERACTIVE;

EID: 34547153761     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610701359621     Document Type: Article

References (8)

1. Boy S, Reitz A, Wirth A et al. 2005. Facilitatory neuromodulative effect of duloxetine on urethral sphincter motor neurones in healthy females. Abstract 998. European Urology 4(Suppl.):253.
2. Bump R, Norton P, Zinner N et al. 2003. Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response. Obstetrics and Gynecology 102:76-83.
3. Dmochowski R, Miklos J, Norton P et al. 2003. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. Journal of Urology 170:1259-1263.
4. Millard R, Moore K, Rencken R et al. 2004. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomised clinical trial. BJU International 93:311-318.
5. Norton P, Zinner N, Yalcin I et al. 2002. Duloxetine versus placebo in the treatment of stress urinary incontinence. American Journal of Obstetrics and Gynecology 187:40-48.
6. Thor KB, Katofiasc MA. 1995. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anaesthetized female cat. Journal of Pharmacology and Experimental Therapeutics 274:1014-1024.
7. Van Kerrebroek P, Abrams P, Lange R et al. 2004. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. British Journal of Obstetrics and Gynaecology 111:249-257.
8. Yalcin I, Bump RC. 2003. Validation of two global impression questionnaires for incontinence. American Journal of Obstetrics and Gynecology 189:98-101.